login
  Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 

Terumo introduces Azur Detachable 35 Peripheral Framing Coil


Monday, 02 Apr 2012 12:34
Azur coils
Azur coils

Terumo Interventional Systems, one of the leading manufacturers of guidewires, catheters, sheaths, and embolization products, has announced the US availability of the Azur D35 Framing Coil for peripheral embolization procedures.


Azur is indicated for peripheral embolization procedures where a scaffolding structure is needed, such as: hypogastric artery embolization; peripheral arteriovenous malformations and fistulas; endoleaks; visceral aneurysms; and venous applications. The detachable embolic platform forms a spherical 3-dimensional shape when deployed and is designed to control the first coil deployment, when a standard coil would not suffice due to high flow and high pressures.


“The new Azur D35 Framing Coils’ innovative technology offers interventional radiologists and vascular surgeons options in challenging, high-flow procedures,” said Chris Pearson, vice president, Marketing, Terumo Interventional Systems. “These detachable framing coils afford greater filling capacity, packing density, and mechanical occlusion, particularly in the treatment of high-flow and challenging blood vessels, vascular malformations, and aneurysms.”


“The detachable technology allows the physician to optimise the framing coil placement, creating support for subsequent coils,” said Pearson. “Azur D35 Hydrogel coils expand gradually upon exposure to blood, which provides improved volumetric filling allowing highly effective, targeted embolization.”




Add New Comment

Most popular


OVER analysis: Endoleak does not predict reduced long-term survival but negatively impacts sac regression
Wednesday, 18 Jun 2014
An analysis of the OVER trial presented at the Society for Vascular Surgery Vascular Annual Meeting (SVS, 5–7 June, Boston, USA) shows that the development of endoleaks were common in patients ... OVER analysis: Endoleak does not predict reduced long-term survival but negatively impacts sac regression

Medtronic to acquire Covidien for US$42.9 billion in cash and stock
Monday, 16 Jun 2014
The acquistion creates a medical technology and services company with a comprehensive product portfolio and broad global reach. Medtronic to acquire Covidien for US$42.9 billion in cash and stock

FDA advisory panel unanimously recommends approval for Lutonix DCB
Friday, 13 Jun 2014
Lutonix DCB is one step closer to becoming the first US FDA-approved drug-coated balloon for the treatment of patients with femoropopliteal occlusive disease. FDA advisory panel unanimously recommends approval for Lutonix DCB

Features


The 11th Scientific Meeting of the Chinese Society of Interventional Radiology successfully held in Changsha
Tuesday, 08 Jul 2014
The 11th Scientific Meeting of the Chinese Society of Interventional Radiology (2014 CSIR) was held from 11–15 June 2014 in Changsha, Hunan Province, China. The Chinese Society of Interventional R... The 11th Scientific Meeting of the Chinese Society of Interventional Radiology successfully held in Changsha

Pressure-directed embolotherapy using antireflux devices to perform liver directed regional therapy
Tuesday, 08 Jul 2014
Unintended non-target delivery of embolic agents into any of the various hepaticoentric arteries that course from an intrahepatic artery to implant into an extra hepatic organ such as the stomach or ... Pressure-directed embolotherapy using antireflux devices to perform liver directed regional therapy

Profiles


Bien Soo Tan
Friday, 16 May 2014
Bien Soo Tan, senior consultant, Department of Diagnostic Radiology, Singapore General Hospital, S... Bien Soo Tan

James B Spies
Friday, 16 May 2014
The evolution of embolization over the past decade has been remarkable and it has fundamentally ... James B Spies

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions